1. Home
  2. TRNO vs GRFS Comparison

TRNO vs GRFS Comparison

Compare TRNO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRNO
  • GRFS
  • Stock Information
  • Founded
  • TRNO 2009
  • GRFS 1940
  • Country
  • TRNO United States
  • GRFS Spain
  • Employees
  • TRNO N/A
  • GRFS N/A
  • Industry
  • TRNO Real Estate
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRNO Finance
  • GRFS Health Care
  • Exchange
  • TRNO Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • TRNO 6.0B
  • GRFS 6.6B
  • IPO Year
  • TRNO 2010
  • GRFS 2006
  • Fundamental
  • Price
  • TRNO $59.88
  • GRFS $8.29
  • Analyst Decision
  • TRNO Buy
  • GRFS Hold
  • Analyst Count
  • TRNO 10
  • GRFS 1
  • Target Price
  • TRNO $64.40
  • GRFS $10.30
  • AVG Volume (30 Days)
  • TRNO 640.2K
  • GRFS 707.0K
  • Earning Date
  • TRNO 11-03-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • TRNO 3.54%
  • GRFS 1.70%
  • EPS Growth
  • TRNO 75.67
  • GRFS 132.60
  • EPS
  • TRNO 3.15
  • GRFS 0.53
  • Revenue
  • TRNO $442,611,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • TRNO $21.54
  • GRFS $5.31
  • Revenue Next Year
  • TRNO $10.87
  • GRFS $6.02
  • P/E Ratio
  • TRNO $18.71
  • GRFS $20.72
  • Revenue Growth
  • TRNO 21.13
  • GRFS 9.32
  • 52 Week Low
  • TRNO $48.18
  • GRFS $6.19
  • 52 Week High
  • TRNO $69.20
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • TRNO 55.73
  • GRFS 23.86
  • Support Level
  • TRNO $56.09
  • GRFS $8.21
  • Resistance Level
  • TRNO $61.55
  • GRFS $9.90
  • Average True Range (ATR)
  • TRNO 1.17
  • GRFS 0.31
  • MACD
  • TRNO -0.18
  • GRFS -0.11
  • Stochastic Oscillator
  • TRNO 59.97
  • GRFS 4.73

About TRNO Terreno Realty Corporation

Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: